🚨PANDORINA, a binational 🇳🇱🇮🇹RCT of drain 🆚 no drain in distal pancreatectomy out in The Lancet Gastroenterology & Hepatology !
✅Major morbidity 20% vs 15%
✅POPF 27% vs 12%
➡️A no-drain policy is safe and reduced POPF and should be the new standard approach
DPCG thelancet.com/journals/langa…

📣 Check out our latest review article published in @jogs, focusing on state-of-the-art in simultaneous resection for colorectal cancer with synchronous liver metastases

➡️ sciencedirect.com/science/articl…

Timothy M. Pawlik Marcello Di Martino Florian Primavesi Diamantis I. Tsilimigras, MD, PhD Adam Frampton

Out now! How many patients fail to access adjuvant therapy after surgery for resectable #PancreaticCancer ?25%🥧! Why?(Data from 317 pts)
1) 🩹Postop compl
2) 🧑‍⚕️Oncologist's choice
3) 💊Comorbidities
Less likely:
- 👵Elderly
- 💧POPF
Pancreas Verona E-AHPBA IHPBA AnnalsSurgOncology

Laparoscopic Liver Tunnel for Tumors at the Hepatocaval Confluence ⁦AnnalsSurgOncology⁩ link.springer.com/article/10.124…

👉 In PancreasGroup.org 2 we now seek to investigate aspects contributing to FTR on a hospital and institutional level, across various Human Development Index countries, aiming to further improve patient care and safety in pancreatic surgery 🌏🌍🌎

🎁 It's that time of the year...

🎄 Best of Pancreas Wrapped 2023!!! 🍾

1⃣ January 2023: Pancreatic cysts when to stop surveillance !? 👇👇👇

What is the difference between long-term survival and cure following pancreatectomy for PDAC? Check this out: Cure Probabilities After Resection Of Pancreatic Ductal... : Annals of Surgery journals.lww.com/annalsofsurger… Stefano Crippa Giuseppe Malleo Alessandro Cucchetti AICEP AISP

Today in Nature Reviews Gastroenterology & Hepatology, review BRPC-LAPC #PancreaticCancer

📌 Preoperative chemotherapy & radiation
📌 A-B-C (re)staging & surgical decision-making
📌Clinical research agenda

Great team effort 🇩🇪🇺🇸🇳🇱 nature.com/articles/s4157…

Outcomes from the PancreasGroup.org are now publsihed in BJS !

🚨Get ready for PancreasGroup 2, coming soon!

pancreasgroup.org

Paris ‘98 Prof. Makuuchi & Belghiti started “HCC East-West Experiences”Myself, Prof. Kokudo & Jean-Nicolas Vauthey MD joined. Milan ‘15: became EWALT. Mainz Nov 8-10, Prof Hauke Lang hosts EWALT 2023: join ewalt2023.de !
IHPBA E-AHPBA APHPBA2023 IASGO_1988 SSAT AICEP

While >1000 worldexperts meet European Society of Surgical Oncology (ESSO) congress #esso42 in beautiful Florence to improve care & save cancer patients life, in other parts of the world young, healthy humans and elderly people are getting killed daily. Why are we wasting the precious gift of life? #stopallwars

In Zurich🇨🇭for the 5th Congress of International Advanced HPB Surgery 🌍 #ISLS2023

ISLS - International Society of Liver Surgeons

RAPID Consensus session under way now!

A comprehensive paper by Mimmo Tamburrino on the surgical approach for BL and LA #PancreaticCancer . JOGS Ospedale San Raffaele Università Vita-Salute San Raffaele Stefano Crippa IHPBA EPC-Europ Pancr Club European Society of Surgical Oncology (ESSO)
link.springer.com/article/10.100…

The HPB Cases📂
Online session 1 - The modern management of a patient with colorectal-liver metastases
📆Thur 12th October
⏰ 1800 GMT / 1900 CEST
Free registration - eahpba.org/education-and-…

IHPBA European Society of Surgical Oncology (ESSO) Somaiah Aroori Marcello Di Martino Anita Balakrishnan

Out now the 3-year results of the Italian Registry of PDAC Surveillance: a multicenter (18🏥) effort: 8 PDAC, 1 PanIN3, and 1-, 2- and 3-year cum haz of 1.7%, 2.5% and 3%📈. Thanks all🙏AISP Gabriele Capurso MD, PhD🇺🇦 EPC-Europ Pancr Club Pancreas Verona The PRECEDE Consortium Study E-AHPBA Fondazione Nadia Valsecchi Onlus

Low-yield surgery during pancreatic cancer surveillance: prevention or overtreatment? Definitely a thin border! A prevalence metanalysis. Check this out! Pancreas Verona Gabriele Capurso MD, PhD🇺🇦 Diane M. Simeone, MD Kasper.Overbeek James Farrell Giuseppe Malleo The PRECEDE Consortium Study IHPBA E-AHPBA my_UEG

“Living donor liver to Live: The Gift of a Second Chance!' - “The high-MELD LDLT group had similar patient and graft survival and morbidities to the low-MELD LDLT group, despite being at higher risk for pulmonary infection, abdominal fluid collection and prolonged ICU stay”…

Early cholecystectomy 🫛 after moderate and severe acute biliary pancreatitis !?

😨 Mortality as high as 15%

🫸 Elderly and fragile patients manifesting severe complications are at relevant risk of morbidity and might not benefit!

👉jamanetwork.com/journals/jamas…

🌍 3696 pt.
EC presented ⬆️ risk of mort.
⚠ Older/fragile pt. with AP-related compl. should likely not be considered for EC

🙏 Mauro Podda, leader of the #MANCTRA -1 project |🙏ACIE Associazione Chirurghi Italiani in Europa for the opportunity to work on such a significant research

IHPBA E-AHPBA AICEP CE-IHPBA